SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001104659-21-073362
Filing Date
2021-05-27
Accepted
2021-05-27 17:28:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B2 tm2116866-6_424a.htm 424B2 1099342
2 GRAPHIC lg_astrazeneca-4clr.jpg GRAPHIC 40130
  Complete submission text file 0001104659-21-073362.txt   1156382
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-256406 | Film No.: 21974358
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1209 ORANGE STREET WILMINGTON DE 19801
Business Address 1209 ORANGE STREET WILMINGTON DE 19801 1-800-677-3394
AstraZeneca Finance LLC (Filer) CIK: 0001862005 (see all company filings)

IRS No.: 000000000
Type: 424B2 | Act: 33 | File No.: 333-256406-01 | Film No.: 21974359